BREATHING SCIENCE INTO LIFE

What this means for you

Not registered yet, but its 08 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79430064

Mark type

Stylized text

Filed

08 Jul 2025

Goods and services

• Class 001 — Chemicals: Biological preparations, other than for medical or veterinary purposes, for boosting cells in the immune system for improved therapies; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use; proteins for use in science; regulatory proteins for scientific use.
• Class 005 — Pharmaceuticals: Medical, biological, pharmaceutical and veterinary preparations; medical, biological, pharmaceutical and veterinary preparations for preventing and treating infectious diseases, medical disorders, and diseases; medical, biological, pharmaceutical and veterinary preparations for preventing and treating infections such as viral, bacterial and yeast infections; medical, biological, pharmaceutical and veterinary preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; regulatory proteins for medical use; compounds for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases of the respiratory system; diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use.
• Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; custom manufacture of pharmaceuticals, biopharmaceuticals and vaccines in relation to cell therapy, gene editing, protein replacement, and antibodies; provision of information, advice and consultancy services relating to all of the aforesaid services.
• Class 042 — Scientific and technological services: Biological research, clinical research and medical research; pharmaceutical research and development services; pharmaceutical products development; pharmaceutical product evaluation; research relating to pharmaceuticals; testing of pharmaceuticals; pharmaceutical and medical research and development services for the treatment of various medical disorders, cancer, pulmonary diseases and infectious diseases; vaccine research and development services; research and development in the field of microorganisms and cells; development of gene-based medicines; drug discovery services; conducting clinical trials for pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals; chemical research and analysis services; medical research and development services; pharmacological research services; scientific research and development; scientific research for medical purposes; scientific research for medical purposes in the area of diseases; conducting clinical trials; scientific research in the field of genetics and genetic engineering; genetic research; genetic mapping for scientific purposes; DNA screening for scientific research purposes; dna analysis services for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; biotechnological research relating to enzymatic synthesis; technical research in the field of pharmaceutical studies; toxicity testing for research purposes; toxicity analysis; information technology services for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; software as a service (SaaS) featuring artificial intelligence software for healthcare; software as a service (SaaS) featuring software relating to the medical field; veterinary research; provision of information and data relating to medical and veterinary research and development.

Owner

• PNEOO B.V., BE

Prosecution history

• 29 Jan 2026 — REFUSAL PROCESSED BY IB
• 09 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 09 Jan 2026 — REFUSAL PROCESSED BY MPU
• 09 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 08 Jan 2026 — NON-FINAL ACTION WRITTEN
• 07 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
• 02 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 01 Dec 2025 — NON-FINAL ACTION WRITTEN
• 25 Nov 2025 — ASSIGNED TO EXAMINER
• 14 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
• 15 Aug 2025 — APPLICATION FILING RECEIPT MAILED
• 15 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 14 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB